MYC and liver cancer: It was confirmed that the double transgenic mouse model manifested the occurrence of liver cancer in 100% of males and 30% of females at 8 months of age, and the double transgenic mice developed liver cancer earlier than the mice that overexpressed c-myc or TGF-α alone.